Blood eosinophilia as predictor for outcomes in COPD exacerbations: a systematic review and meta-analysis Source: International Congress 2017 – Management of COPD Year: 2017
Impact of blood eosinophil variability in asthma: a real-life population study. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Determinants of blood eosinophil count in adults from a large population-based study Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
Blood eosinophil level and lung function trajectories: cross-sectional and longitudinal studies in European cohorts Source: ERJ Open Res, 6 (4) 00320-2020; 10.1183/23120541.00320-2020 Year: 2020
Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease Source: Eur Respir J 2016; 47:1299-1303 Year: 2016
ERJ October Podcast: blood eosinophil count as a biomarker in patients with airway disease Source: Eur Respir J 2016; 48: E70 Year: 2016
Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019
Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Peripheral eosinophil count as a biomarker for the management of COPD: not there yet Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017 Year: 2017
Blood eosinophil count in the general population: typical values and potential confounders Source: Eur Respir J, 55 (5) 1901874; 10.1183/13993003.01874-2019 Year: 2020
Interpreting blood eosinophil counts in health and obstructive lung disease Source: Eur Respir J, 59 (1) 2102180; 10.1183/13993003.02180-2021 Year: 2022
Lower airways bacterial profile in healthy subjects and COPD. A meta-analytical review of protected specimen brush studies Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001
The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015
Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study Source: Eur Respir J, 51 (5) 1702523; 10.1183/13993003.02523-2017 Year: 2018
Blood eosinophils and obstructive lung disease in the general population Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018
Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
The search for the “healthy” blood eosinophil count Source: Eur Respir J, 55 (5) 2000473; 10.1183/13993003.00473-2020 Year: 2020
Blood inflammatory phenotypes of asthma in the Constances cohort Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019
Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017